Search results for: result

Need a new search?

If you didn't find what you were looking for, try a new search!

How to do a Trademark search?

By |2017-10-14T16:12:48+05:30October 14th, 2017|Trademark|

Overview A trademark is any name, word, phrase, logo, design or symbol that businesses and companies use to assign an identity or distinguishing feature for their goods or products, effectively setting them apart from those of other manufacturers or sellers. The trademark instantly brings about recognition to any customer that sees it. The moment [...]

Compulsory Licensing under Copyright Law

By |2017-10-13T17:44:31+05:30October 13th, 2017|Copyright|

Compulsory License is the term generally applied to a statutory license to do an act covered by an exclusive right without the prior authorization of the right owner. Compulsory licensing allowed was for the use of protected without prior permission of the owner of the right. Copyright is the monopoly granted in exchange or as [...]

Apple patents for Intelligent Blood Pressure Monitoring

By |2017-10-13T13:06:51+05:30October 13th, 2017|Patent|

A freshly surfaced patent details a smart blood pressure monitoring system device that would automatically measure a user's blood pressure. The patent was published by the USPTO, though it shows that Apple filed it back. In its, the company refers to the system as an "Intelligent Blood Pressure Monitoring" technology.  Abstract In some implementations, a [...]

How to check if a Trademark is already registered?

By |2017-10-13T11:51:35+05:30October 13th, 2017|Trademark|

Distinctive design, graphics, logo, symbols, words, or any combination thereof that uniquely identifies a firm and/or its goods or services, guarantees the item's genuineness, and gives it owner the legal rights to prevent the trademark's unauthorized use. A trademark must be (1) distinctive instead of descriptive, (2) affixed to the item sold, and (3) [...]

Nokia focuses patents,brands and technology for faster growth

By |2017-10-10T14:54:50+05:30October 10th, 2017|IP Basics|

As suggested by Press Release: Increased focus on digital health and brand and technology licensing balanced with optimized investment in virtual reality. Planned changes expected to impact Nokia Technologies employees mainly in Finland, the US and the UK. Nokia successful patent licensing business is not in the scope of planned changes. Today Nokia announced its [...]

A New Dawn for Trademark in China

By |2017-10-10T11:52:50+05:30October 10th, 2017|Trademark|

The recent ruling by a Chinese court in a trademark infringement dispute concerning New Balance's logo marks a watershed moment in China's Intellectual Property regime. The Court awarded a landmark decision in favor of New Balance against Chinese competitors deemed to have infringed the company's IPR, reflecting China's recent effort to improve IPR protection. While [...]

Patents in Unified Patent Court

By |2017-10-10T10:24:34+05:30October 9th, 2017|IP Basics, Patent|

What are the criteria for patentability in your area? The unified patent court will have jurisdiction to hear claims relating to both European patents and upcoming European patent with unitary effect. The European Patent Office will grant the unitary patent in accordance with European Patent Convention. The pre-grant procedure and requirements to obtain unitary patents will be [...]

Drug Lobby’s Patent law

By |2017-10-09T15:33:35+05:30October 9th, 2017|Patent|

Europe is attempting to play mediator in a politically charged, high-stakes disputes involving one of the most powerful industries i.e, the drug lobby. The pharmaceutical industry has a host of intellectual property rights to choose from to protect its novel medicines from competitors once they are approved for sale. These include patents,additional protection once patents [...]

Why Regeneron win is worse for Amgen than you think?

By |2017-10-07T15:09:31+05:30October 7th, 2017|Patent|

Amgen patent covering LDL cholestrol lowering drug Reapatha are likely to be invalidated in the wake of a courtbattle with Regeneron Pharmaceutical and Sanofi. Recently, a federal judge tossed an injunction on sales of Praluent, Regenron and Sanofi will argue that Amgen's patent are too broad. The judge's decision on Thursday effectively ended [...]

How do i protect my Intellectual property rights overseas?

By |2017-10-05T17:21:18+05:30October 5th, 2017|Copyright, Patent, Trademark|

Since the rights granted by the U.S.Patent extend only throughout the territory of united states and no effect on foreign country, an inventor who wishes patent protection in other countries must apply for a patent in each of the other countries or in regional patent offices. Almost every country has its own patent law, and [...]

Go to Top